Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-23

Clinical Trial Update: The Effects of Dexmedetomidine on cTnI and GP-BB in Patients Undergoing OPCABG [NA]

View source ↗

Summary

Clinical trial update examining the effects of dexmedetomidine on cardiac biomarkers (cTnI) and GP-BB in patients undergoing off-pump coronary artery bypass gra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: General Hospital of Ningxia Medical University | Conditions: Coronary Artery Bypass, Off-Pump | NA | Status: UNKNOWN